Travere Therapeutics (TVTX) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of$0.58. This compares to loss of $1.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25.86$0.70 per share when it actually produced a loss of $0.70, delivering no surprise.Over the last four quarters, the company has not ...